Elongation of fatty acids protein, responsible for very long carbon chain llipid biosynthesis (conserved in Eukaryota).. This group of enzymes has expanded heavily in kinetoplastids.. Localization: ER (by homology)
Fatty acid metabolism, Elongation of fatty acids
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 45 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 31 |
NetGPI | no | yes: 0, no: 32 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 29 |
GO:0110165 | cellular anatomical entity | 1 | 30 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A4HW08
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 33 |
GO:0006629 | lipid metabolic process | 3 | 33 |
GO:0006631 | fatty acid metabolic process | 4 | 33 |
GO:0006633 | fatty acid biosynthetic process | 5 | 33 |
GO:0008152 | metabolic process | 1 | 33 |
GO:0008610 | lipid biosynthetic process | 4 | 33 |
GO:0009058 | biosynthetic process | 2 | 33 |
GO:0009987 | cellular process | 1 | 33 |
GO:0016053 | organic acid biosynthetic process | 4 | 33 |
GO:0019752 | carboxylic acid metabolic process | 5 | 33 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 33 |
GO:0043436 | oxoacid metabolic process | 4 | 33 |
GO:0044237 | cellular metabolic process | 2 | 33 |
GO:0044238 | primary metabolic process | 2 | 33 |
GO:0044249 | cellular biosynthetic process | 3 | 33 |
GO:0044255 | cellular lipid metabolic process | 3 | 33 |
GO:0044281 | small molecule metabolic process | 2 | 33 |
GO:0044283 | small molecule biosynthetic process | 3 | 33 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 33 |
GO:0071704 | organic substance metabolic process | 2 | 33 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 33 |
GO:1901576 | organic substance biosynthetic process | 3 | 33 |
GO:0000038 | very long-chain fatty acid metabolic process | 5 | 4 |
GO:0001676 | long-chain fatty acid metabolic process | 5 | 3 |
GO:0006643 | membrane lipid metabolic process | 4 | 4 |
GO:0006665 | sphingolipid metabolic process | 4 | 4 |
GO:0006807 | nitrogen compound metabolic process | 2 | 4 |
GO:0019367 | fatty acid elongation, saturated fatty acid | 7 | 4 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 7 | 4 |
GO:0030148 | sphingolipid biosynthetic process | 5 | 4 |
GO:0030497 | fatty acid elongation | 6 | 4 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 8 | 4 |
GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 8 | 4 |
GO:0042759 | long-chain fatty acid biosynthetic process | 6 | 3 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 6 | 4 |
GO:0046467 | membrane lipid biosynthetic process | 4 | 4 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 4 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 33 |
GO:0004312 | fatty acid synthase activity | 5 | 33 |
GO:0009922 | fatty acid elongase activity | 6 | 33 |
GO:0016740 | transferase activity | 2 | 33 |
GO:0016746 | acyltransferase activity | 3 | 33 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 33 |
GO:0102756 | very-long-chain 3-ketoacyl-CoA synthase activity | 5 | 33 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 229 | 233 | PF00082 | 0.528 |
CLV_PCSK_SKI1_1 | 279 | 283 | PF00082 | 0.198 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.358 |
DOC_CYCLIN_yCln2_LP_2 | 199 | 205 | PF00134 | 0.547 |
DOC_CYCLIN_yCln2_LP_2 | 50 | 56 | PF00134 | 0.523 |
DOC_MAPK_MEF2A_6 | 201 | 209 | PF00069 | 0.458 |
DOC_MAPK_MEF2A_6 | 57 | 64 | PF00069 | 0.495 |
DOC_PP1_RVXF_1 | 142 | 148 | PF00149 | 0.545 |
DOC_PP2B_LxvP_1 | 50 | 53 | PF13499 | 0.523 |
DOC_PP4_FxxP_1 | 40 | 43 | PF00568 | 0.316 |
DOC_USP7_UBL2_3 | 44 | 48 | PF12436 | 0.456 |
DOC_WW_Pin1_4 | 56 | 61 | PF00397 | 0.418 |
LIG_14-3-3_CanoR_1 | 146 | 151 | PF00244 | 0.467 |
LIG_AP2alpha_1 | 132 | 136 | PF02296 | 0.395 |
LIG_APCC_ABBA_1 | 264 | 269 | PF00400 | 0.380 |
LIG_EH1_1 | 178 | 186 | PF00400 | 0.356 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.215 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.464 |
LIG_FHA_1 | 250 | 256 | PF00498 | 0.342 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.399 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.506 |
LIG_FHA_1 | 82 | 88 | PF00498 | 0.234 |
LIG_FHA_1 | 95 | 101 | PF00498 | 0.265 |
LIG_LIR_Apic_2 | 37 | 43 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 134 | 145 | PF02991 | 0.491 |
LIG_LIR_Gen_1 | 154 | 164 | PF02991 | 0.367 |
LIG_LIR_Gen_1 | 261 | 271 | PF02991 | 0.290 |
LIG_LIR_Gen_1 | 47 | 56 | PF02991 | 0.485 |
LIG_LIR_Nem_3 | 134 | 140 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 154 | 160 | PF02991 | 0.313 |
LIG_LIR_Nem_3 | 183 | 189 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 193 | 199 | PF02991 | 0.462 |
LIG_LIR_Nem_3 | 261 | 266 | PF02991 | 0.283 |
LIG_LIR_Nem_3 | 47 | 52 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 77 | 82 | PF02991 | 0.302 |
LIG_Pex14_2 | 132 | 136 | PF04695 | 0.395 |
LIG_Pex14_2 | 147 | 151 | PF04695 | 0.372 |
LIG_Pex14_2 | 157 | 161 | PF04695 | 0.341 |
LIG_Pex14_2 | 263 | 267 | PF04695 | 0.294 |
LIG_SH2_GRB2like | 49 | 52 | PF00017 | 0.523 |
LIG_SH2_PTP2 | 159 | 162 | PF00017 | 0.322 |
LIG_SH2_PTP2 | 30 | 33 | PF00017 | 0.222 |
LIG_SH2_SRC | 224 | 227 | PF00017 | 0.373 |
LIG_SH2_STAP1 | 113 | 117 | PF00017 | 0.249 |
LIG_SH2_STAP1 | 260 | 264 | PF00017 | 0.266 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.277 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.304 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 186 | 189 | PF00017 | 0.313 |
LIG_SH2_STAT5 | 206 | 209 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 224 | 227 | PF00017 | 0.284 |
LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.273 |
LIG_SH2_STAT5 | 260 | 263 | PF00017 | 0.327 |
LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.309 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.298 |
LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.418 |
LIG_SH3_1 | 57 | 63 | PF00018 | 0.495 |
LIG_SH3_3 | 57 | 63 | PF00018 | 0.454 |
LIG_SH3_3 | 84 | 90 | PF00018 | 0.360 |
LIG_UBA3_1 | 123 | 128 | PF00899 | 0.320 |
LIG_UBA3_1 | 91 | 96 | PF00899 | 0.328 |
LIG_WRC_WIRS_1 | 104 | 109 | PF05994 | 0.297 |
LIG_WRC_WIRS_1 | 35 | 40 | PF05994 | 0.359 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.218 |
MOD_CK1_1 | 246 | 252 | PF00069 | 0.306 |
MOD_CMANNOS | 69 | 72 | PF00535 | 0.374 |
MOD_GlcNHglycan | 221 | 224 | PF01048 | 0.386 |
MOD_GlcNHglycan | 245 | 248 | PF01048 | 0.536 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.363 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.304 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.314 |
MOD_N-GLC_1 | 65 | 70 | PF02516 | 0.310 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.257 |
MOD_NEK2_1 | 124 | 129 | PF00069 | 0.319 |
MOD_NEK2_1 | 132 | 137 | PF00069 | 0.330 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.458 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.137 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.301 |
MOD_NEK2_1 | 205 | 210 | PF00069 | 0.497 |
MOD_NEK2_1 | 219 | 224 | PF00069 | 0.275 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.250 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.306 |
MOD_Plk_1 | 65 | 71 | PF00069 | 0.492 |
MOD_Plk_4 | 132 | 138 | PF00069 | 0.308 |
MOD_Plk_4 | 146 | 152 | PF00069 | 0.450 |
MOD_Plk_4 | 167 | 173 | PF00069 | 0.289 |
MOD_Plk_4 | 180 | 186 | PF00069 | 0.278 |
MOD_ProDKin_1 | 56 | 62 | PF00069 | 0.418 |
TRG_DiLeu_BaLyEn_6 | 87 | 92 | PF01217 | 0.434 |
TRG_ENDOCYTIC_2 | 159 | 162 | PF00928 | 0.326 |
TRG_ENDOCYTIC_2 | 186 | 189 | PF00928 | 0.332 |
TRG_ENDOCYTIC_2 | 206 | 209 | PF00928 | 0.137 |
TRG_ENDOCYTIC_2 | 260 | 263 | PF00928 | 0.280 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.299 |
TRG_ENDOCYTIC_2 | 35 | 38 | PF00928 | 0.298 |
TRG_ENDOCYTIC_2 | 49 | 52 | PF00928 | 0.457 |
TRG_ER_diArg_1 | 276 | 279 | PF00400 | 0.540 |
TRG_ER_diLys_1 | 282 | 285 | PF00400 | 0.681 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5E5 | Leptomonas seymouri | 32% | 95% |
A0A0N0P7D1 | Leptomonas seymouri | 31% | 85% |
A0A0N0P7D6 | Leptomonas seymouri | 42% | 99% |
A0A0N0P7R2 | Leptomonas seymouri | 33% | 93% |
A0A0N1HZJ8 | Leptomonas seymouri | 27% | 88% |
A0A0N1I9H5 | Leptomonas seymouri | 51% | 100% |
A0A0N1IIZ8 | Leptomonas seymouri | 25% | 93% |
A0A0N1ILQ4 | Leptomonas seymouri | 37% | 97% |
A0A0N1IM10 | Leptomonas seymouri | 85% | 100% |
A0A0N1PDR8 | Leptomonas seymouri | 27% | 100% |
A0A0N1PFE8 | Leptomonas seymouri | 52% | 100% |
A0A0S4IS29 | Bodo saltans | 34% | 100% |
A0A0S4IVJ6 | Bodo saltans | 28% | 90% |
A0A0S4IVS6 | Bodo saltans | 34% | 100% |
A0A0S4IW98 | Bodo saltans | 33% | 90% |
A0A1X0NNK7 | Trypanosomatidae | 33% | 100% |
A0A1X0NNL0 | Trypanosomatidae | 38% | 94% |
A0A1X0NNM4 | Trypanosomatidae | 38% | 100% |
A0A1X0NNM5 | Trypanosomatidae | 28% | 93% |
A0A1X0NP89 | Trypanosomatidae | 26% | 89% |
A0A3Q8I8T7 | Leishmania donovani | 26% | 73% |
A0A3Q8I9T2 | Leishmania donovani | 29% | 76% |
A0A3Q8I9U9 | Leishmania donovani | 28% | 87% |
A0A3Q8I9X8 | Leishmania donovani | 32% | 85% |
A0A3Q8IC05 | Leishmania donovani | 33% | 93% |
A0A3Q8ID51 | Leishmania donovani | 30% | 72% |
A0A3Q8IIA9 | Leishmania donovani | 49% | 100% |
A0A3R7KG78 | Trypanosoma rangeli | 33% | 100% |
A0A3R7MJR2 | Trypanosoma rangeli | 40% | 100% |
A0A3R7NSQ3 | Trypanosoma rangeli | 38% | 99% |
A0A3S5H6R7 | Leishmania donovani | 100% | 100% |
A0A3S5H6R8 | Leishmania donovani | 36% | 97% |
A0A3S7WSY8 | Leishmania donovani | 53% | 100% |
A0A3S7WSZ1 | Leishmania donovani | 31% | 95% |
A0A3S7WT03 | Leishmania donovani | 30% | 95% |
A0A3S7WT05 | Leishmania donovani | 23% | 93% |
A0A3S7WT16 | Leishmania donovani | 29% | 89% |
A0A422NNP1 | Trypanosoma rangeli | 28% | 95% |
A4H7M1 | Leishmania braziliensis | 22% | 100% |
A4H7M2 | Leishmania braziliensis | 55% | 100% |
A4H7M3 | Leishmania braziliensis | 95% | 100% |
A4H7M4 | Leishmania braziliensis | 48% | 100% |
A4H7M5 | Leishmania braziliensis | 35% | 100% |
A4H7M6 | Leishmania braziliensis | 29% | 100% |
A4H7M7 | Leishmania braziliensis | 30% | 100% |
A4H7M8 | Leishmania braziliensis | 29% | 75% |
A4H7N0 | Leishmania braziliensis | 33% | 100% |
A4HW06 | Leishmania infantum | 23% | 100% |
A4HW07 | Leishmania infantum | 53% | 99% |
A4HW09 | Leishmania infantum | 49% | 100% |
A4HW10 | Leishmania infantum | 36% | 97% |
A4HW12 | Leishmania infantum | 33% | 85% |
A4HW13 | Leishmania infantum | 28% | 87% |
A4HW14 | Leishmania infantum | 29% | 88% |
A4HW15 | Leishmania infantum | 29% | 76% |
A4HW16 | Leishmania infantum | 31% | 76% |
A4HW17 | Leishmania infantum | 26% | 73% |
A4HW18 | Leishmania infantum | 33% | 94% |
B4QVX4 | Drosophila simulans | 26% | 100% |
C9ZT13 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 95% |
C9ZT15 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
C9ZT16 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 93% |
E8NHR2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E8NHR3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9AGL0 | Leishmania infantum | 29% | 95% |
E9AGL2 | Leishmania infantum | 31% | 95% |
E9APQ8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 22% | 100% |
E9APQ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 53% | 100% |
E9APR0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
E9APR1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 49% | 100% |
E9APR2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
E9APR3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 99% |
E9APR4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 99% |
E9APR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
E9APR6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9APR7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9APR9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
G5EEE5 | Caenorhabditis elegans | 25% | 99% |
O35949 | Mus musculus | 29% | 100% |
P39540 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 92% |
P40319 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 30% | 83% |
P49191 | Caenorhabditis elegans | 27% | 89% |
Q20300 | Caenorhabditis elegans | 30% | 100% |
Q20303 | Caenorhabditis elegans | 29% | 100% |
Q4QFQ9 | Leishmania major | 33% | 100% |
Q4QFR2 | Leishmania major | 31% | 100% |
Q4QFR3 | Leishmania major | 29% | 100% |
Q4QFR4 | Leishmania major | 27% | 100% |
Q4QFR5 | Leishmania major | 33% | 100% |
Q4QFR6 | Leishmania major | 29% | 100% |
Q4QFR7 | Leishmania major | 36% | 100% |
Q4QFR8 | Leishmania major | 49% | 100% |
Q4QFR9 | Leishmania major | 99% | 100% |
Q4QFS0 | Leishmania major | 54% | 99% |
Q4QFS1 | Leishmania major | 23% | 100% |
Q5ZJR8 | Gallus gallus | 31% | 100% |
Q6PC64 | Danio rerio | 35% | 100% |
Q920L5 | Mus musculus | 35% | 100% |
Q920L6 | Rattus norvegicus | 35% | 100% |
Q9H5J4 | Homo sapiens | 34% | 100% |
Q9HB03 | Homo sapiens | 30% | 100% |
Q9VH58 | Drosophila melanogaster | 26% | 100% |
Q9VV87 | Drosophila melanogaster | 30% | 90% |
Q9XVQ9 | Caenorhabditis elegans | 27% | 100% |
V5BE99 | Trypanosoma cruzi | 30% | 99% |
V5BIX9 | Trypanosoma cruzi | 40% | 100% |
V5BND3 | Trypanosoma cruzi | 28% | 95% |
V5DF68 | Trypanosoma cruzi | 39% | 99% |